BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Genexine to test toxicity of immunotherapeutic drug candidate for intranasal administration

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : August 18, 2020, 15:09 | Updated : August 18, 2020, 15:09
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of Genexine]

SEOUL -- Genexine, a clinical-stage biotechnology company involved in a state-commissioned research consortium to develop a DNA vaccine material for COVID-19, will conduct a pre-clinical test to confirm the toxicity of its immunotherapeutic drug candidate, GX-I7, by spraying it to the nasal cavity.

According to Genexine, the intranasal administration method prevents virus infection for 5 to 35 days by increasing lymphocytes that control the immune system in the airway mucosa area where GX-I7 is applied. The study will be done with the support of the Research Investment for Global Health Technology (RIGHT) Fund, which is a funding agency dedicated to supporting global health research and development.

Genexine and its U.S. co-developer NeoImmuneTech, a clinical-stage T cell-focused bio company, have secured approval from the Food and Drug Administration to conduct Phase 1 clinical trials for GX-I7 to see if it is effective in the treatment of COVID-19. Genexine has said that GX-I7 showed good efficacy when used in combination with a variety of immunotherapeutic agents.

South Korea has unveiled a roadmap for the treatment of COVID-19 to develop plasma treatment by the year's end as well as antibody treatment and vaccines next year.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Semiconductor-based fast test kit using saliva able to debut in March: science minister.
    Semiconductor-based fast test kit using saliva able to debut…
  • .Syringes for COVID-19 vaccines added to list of K-quarantine technologies.
    Syringes for COVID-19 vaccines added to list of 'K-quarantin…
  • .Health officials heave sigh of relief at early introduction of Novavax vaccine .
    Health officials heave sigh of relief at early introduction …
  • .Bukwangs COVID-19 treatment wins FDA approve to go ahead with second-phase clinical trials.
    Bukwang's COVID-19 treatment wins FDA approve to go ahead wi…
  • .Experts give conditional consent to AstraZenecas vaccine for people over 65.
    Experts give conditional consent to AstraZeneca's vaccine fo…

Real Time Photo News

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

  • .[FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene.

    [FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene

  • .CJ ENM aims to become major visual content producer thru partnership with Epic Games .

    CJ ENM aims to become major visual content producer thru partnership with Epic Games

  • .​Solo singer Sunmi to come back with new album Tail.

    ​Solo singer Sunmi to come back with new album 'Tail'

  • .Big Hits live-streaming joint venture gains reinforcements from Universal Music, YG.

    Big Hit's live-streaming joint venture gains reinforcements from Universal Music, YG

Latest News

more+

  • Samsung Electronics develops new technology to improve 5G network performance
  • S. Korea to share know-how of biodegradable fishing net production with Kuwait
  • S. Korea aims to become major player in carbon-based convergence industries
  • Seoul to promote urban green energy harvesting with subsidies
  • LIG Nex1 delivers new military radio sets for simultaneous data transmission and voice communication…
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view